ACC Cardiology Hour | AHA 2023

Nov 13, 2023   |  Valentin Fuster, MD, PhD, MACC; Joshua A. Beckman, MD, MS, FACC; Roxana Mehran, MD, FACC; Pasquale Santangeli, MD; Amanda Vest, MD, FACC

Video Interview
Print
Font Size
A
A
A

In the latest installment of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by expert panelists Joshua A. Beckman, MD, MS, FACC; Roxana Mehran, MD, FACC; Pasquale Santangeli, MD, PhD; and Amanda Vest, MD, in a lively discussion on top late-breaking clinical trials released during AHA's Scientific Sessions 2023. Watch for key takeaways and practice implications of trials including SELECT (3:01), ARTESIA (14:51), AZALEA-TIMI 71 (23:34), ORBITA-2 (33:50). Efficacy and Safety of Lepodisiran (43:26), VERVE-101 (50:43) and KARDIA-1 (58:33). Don't miss the panelists "best of AHA" selections (1:04:32).

A long-standing resource for busy cardiovascular professionals, ACC Cardiology Hour offers multidisciplinary expert discussion on top clinical trials released during cardiology's biggest meetings. Visit https://www.JACC.org/CardiologyHour to see more videos.

The ACC is providing coverage of the latest science being presented at AHA 2023 in Philadelphia. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #AHA23.

Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Atrial Fibrillation/Supraventricular Arrhythmias, Hypertension, Vascular Medicine, Invasive Cardiovascular Angiography and Intervention, Acute Coronary Syndromes, Anticoagulation Management

Keywords: American Heart Association, AHA23, Dyslipidemias, PCSK9, Atrial Fibrillation, Stroke, Glucagon-Like Peptide-1 Receptor, Obesity, Anticoagulation Management, Myocardial Ischemia, Blood Pressure, Hypertension, RNA Interference


< Back to Listings